Complications of intrastromal bevacizumab injection in lamellar keratoplasty
Open Access
- 18 February 2020
- journal article
- letter
- Published by Press of International Journal of Ophthalmology (IJO Press) in International Journal of Ophthalmology
- Vol. 13 (2), 356-358
- https://doi.org/10.18240/ijo.2020.02.22
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Effects of ranibizumab (Lucentis®) and bevacizumab (Avastin®) on human corneal endothelial cellsBMC Ophthalmology, 2018
- Safety of antivascular endothelial growth factor administration in the ocular anterior segment in pterygium and neovascular glaucoma treatmentMedicine, 2018
- Therapeutic approaches for corneal neovascularizationEye and Vision, 2017
- Subconjunctival Bevacizumab Injection Impairs Corneal Innervations and Epithelial Wound Healing in MiceInvestigative Ophthalmology & Visual Science, 2017
- Management of high-risk corneal transplantationSurvey of Ophthalmology, 2016
- Intrastromal Injection of Bevacizumab in the Management of Corneal Neovascularization: About 25 EyesJournal of Ophthalmology, 2016
- La prise en charge des néovaisseaux cornéens avant greffe de cornée : à propos de 112 casJournal Français d'Ophtalmologie, 2016
- Intrastromal Delivery of Bevacizumab Using Microneedles to Treat Corneal NeovascularizationInvestigative Ophthalmology & Visual Science, 2014
- Herpetic Epithelial Keratitis After Intravitreal Injection of Bevacizumab (Avastin)Cornea, 2009
- Corneal neovascularizationCurrent Opinion in Opthalmology, 2001